Tag: malaria

  • Bill & Melinda Gates Foundation commits $1.27bn to fight HIV, Malaria, others

    The Bill & Melinda Gates Foundation — alongside governments, philanthropies, the private sector, NGOs, and global and community leaders — has announced commitments totalling $1.27 billion to improve and save millions of lives.

    According to a statement from the organisation, the commitments were announced during the United Nations General Assembly.

    It said the funding will address overlapping global crises that have reversed the progress already made toward achieving the UN Sustainable Development Goals (Global Goals).

    The total sum of $912 million pledge will go to the Global Fund to Fight AIDS, Tuberculosis and Malaria.

    This is the foundation’s largest commitment yet to the Global Fund.

    According to the statement, since 2002, health programs supported by the Global Fund partnership have saved 50 million lives.

    This funding will help accelerate efforts to end HIV, TB, and malaria by 2030 and build resilient health systems needed to protect against future pandemics.

    It also will be instrumental in reducing the disproportionate impact of these diseases on women and girls, the foundation added.

    Moreso, $100 million is to help alleviate the food crisis disproportionately impacting communities in Africa and South Asia and address its underlying causes.

    In addition, the foundation will double its previous commitment to the Child Nutrition Fund — from $10 million to $20 million.

    “Our investment will support the fund’s expansion beyond ready-to-use therapeutic food to include preventative nutrition products for both women and children,” the statement disclosed.

    Other areas of support include the sum of $200 million to expand global Digital Public Infrastructure and $50 million to the Partners in Health Scholarship Fund to attend the University of Global Health Equity (UGHE) in Rwanda.

    The foundation’s sixth annual Goalkeepers Report notes that nearly every indicator of the Global Goals is off track at the halfway point for achieving them by 2030.

    Despite these challenges, the report highlights opportunities to accelerate progress by investing in long-term solutions and innovative approaches to entrenched issues, including poverty, inequality, and climate change.

    “This week has underscored the urgency of the challenges we face, and the promise of sustainable solutions that save and improve lives,” said Mark Suzman, Gates Foundation CEO. “We can get back on track toward the SDGs, but it’s going to take a new level of collaboration and investment from every sector. That’s why our foundation is significantly stepping up our commitment to helping confront crises now and ensure long-term impact across critical determinants of health and development.”

    (Daily Trust)

  • WHO endorse RTS,S/AS01 malaria vaccine for children.

     

     

    The World Health Organization on Wednesday endorsed the RTS,S/AS01 malaria vaccine, the first against the mosquito-borne disease that kills more than 400,000 people a year, mostly African children.

    The decision followed a review of a pilot programme deployed since 2019 in Ghana, Kenya and Malawi where more than two million doses were given of the vaccine, first made by the pharmaceutical company GSK in 1987.

     

    After reviewing evidence from those countries, WHO said it was “recommending the broad use of the world’s first malaria vaccine”, the agency’s director general Tedros Adhanom Ghebreyesus said.

     

    The WHO said in a statement it was recommending the widespread application of the vaccine among children in sub-Saharan Africa and in other regions with moderate to high malaria transmission.

     

    Many vaccines exist against viruses and bacteria but this was the first time that the WHO recommended for broad use of a vaccine against a human parasite.

    “From a scientific perspective this is a massive breakthrough,” said Pedro Alonso, Director of the WHO Global Malaria Programme.

     

    The vaccine acts against plasmodium falciparum — one of five parasite species and the most deadly.

     

    Malaria symptoms include fever, headaches and muscle pain, then cycles of chills, fever and sweating.

     

    Every two minutes, a child dies of malaria, according to the World Health Organization.

     

    Before the newly recommended vaccine can reach African children, the next step will be funding.

     

    “That will be the next major step… Then we will be set up for scaling of doses and decisions about where the vaccine will be most useful and how it will be deployed,” said Kate O’Brien, Director of WHO’s  Department of Immunization, Vaccines and Biological

    (AFP)

     

     

     

     

     

     

     

    Source: www.punchng.com